Cue biopharma, inc. appoints aaron fletcher to serve as a member of the board of directors of the company

Cue biopharma, inc. announced that it appointed dr. aaron fletcher to serve as a member of the board of directors of the company. dr. fletcher will replace anthony digiandomenico, who resigned as a member of the company’s board of directors on october 3, 2019. dr. fletcher has served as founder and president of bios research, a financial services firm that provides public equity research in the healthcare industry tailored to institutional firms since 2012.
CUE Ratings Summary
CUE Quant Ranking